Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anahit Therapeutics was a Toronto-based private company focused on cannabis-, psilocybin-, and mushroom-related products spanning cultivation, extraction, formulation, packaging, and consumer wellness products. Public disclosures from 2020 indicate the company was positioned around low-cost production in emerging regulated jurisdictions, including work tied to psilocybin cultivation and a wholesale supply model. Through New Wave Holdings' investment, Anahit also moved toward North American functional mushroom nutraceutical products, including powder and capsule formulations made with reishi, cordyceps, lion's mane, oyster, and shiitake mushrooms. Available corporate database sources now characterize Anahit Therapeutics as closed and acquired.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anahit Therapeutics.